Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 10, 2000Journal of Clinical Oncology

Evaluation of the Predictive Value of Her-2/neu Overexpression and p53 Mutations in High-Risk Primary Breast Cancer Patients Treated With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

YNYago NietoPCPablo J. CagnoniSNSamia Nawaz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nieto et al. (2000) studied this question.

synapsesocial.com/papers/6a9012f63dd9003d79c90c25https://doi.org/10.1200/jco.2000.18.10.2070
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Accumulation of p53 Protein as a Possible Predictor of Response to Adjuvant Combination Chemotherapy With Cyclophosphamide, Methotrexate, Fluorouracil, and Prednisone for Breast Cancer1995 · 98 citations
  2. 2p53 and cancer therapy: a double-edged sword1999 · 39 citations
  3. 3Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.1997 · 192 citations
  4. 4High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.1998 · 60 citations
  5. 5High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival.1997 · 79 citations